These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4681074)

  • 1. [The origin of particulate contamination in injectable solutions].
    Lambert G; Moës A
    J Pharm Belg; 1972; 27(4):402-16. PubMed ID: 4681074
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of lead contamination of injectable solutions during simulated compounding and dispensing of radiopharmaceuticals.
    Dansereau RN; Dansereau RJ; Stella M
    Am J Hosp Pharm; 1994 Jul; 51(14):1800-2. PubMed ID: 7942909
    [No Abstract]   [Full Text] [Related]  

  • 3. Particulate-matter content of D5/NS for injection: manufacturer difference and conformance with USP limits.
    Smith JK; Baumann RR; Gunning WT; Annancy L; Alexander KS
    J Parenter Sci Technol; 1988; 42(6):180-6. PubMed ID: 3273493
    [No Abstract]   [Full Text] [Related]  

  • 4. Particulate matter contamination associated with automated compounding TPN solutions.
    Quercia RA
    Am J Hosp Pharm; 1988 Nov; 45(11):2324-5. PubMed ID: 3147592
    [No Abstract]   [Full Text] [Related]  

  • 5. Elimination of particulate contamination from ophthalmic solutions for intraocular surgery.
    Jaffe NS
    Bull Parenter Drug Assoc; 1970; 24(5):218-25. PubMed ID: 5471332
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of the first 6 months' experience in the monitoring of the sterility of injectable solutions].
    Pappalardo G
    Rev Med Suisse Romande; 1986 Feb; 106(2):163-71. PubMed ID: 3515496
    [No Abstract]   [Full Text] [Related]  

  • 7. Monitoring contamination levels of in-use intravenous solutions using "total sample" techniques.
    Hanson AL; Shelley RM
    Am J Hosp Pharm; 1974 Aug; 31(8):733-5. PubMed ID: 4853252
    [No Abstract]   [Full Text] [Related]  

  • 8. [Control of foreign particle contamination of injectable solutions].
    Van Ooteghem M; Moës A
    J Pharm Belg; 1972; 27(4):493-504. PubMed ID: 4681079
    [No Abstract]   [Full Text] [Related]  

  • 9. [ON THE FILTRATION OF INJECTABLE SOLUTIONS IN PHARMACEUTICAL PRACTICE].
    BRAGINSKAIA EN
    Aptechn Delo; 1963; 12():59-62. PubMed ID: 14072500
    [No Abstract]   [Full Text] [Related]  

  • 10. Basics of Sterile Compounding: Particulate Matter.
    Akers MJ
    Int J Pharm Compd; 2017; 21(5):395-404. PubMed ID: 29216617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Particulate contamination of spray-dried and lyophilized injectable carbenicillin.
    Masuda JY; Beckerman JH
    Am J Hosp Pharm; 1974 Dec; 31(12):1189-92. PubMed ID: 4458437
    [No Abstract]   [Full Text] [Related]  

  • 12. USP perspectives on particle contamination of injectable products.
    Gallelli JF; Groves MJ
    J Parenter Sci Technol; 1993; 47(6):289-92. PubMed ID: 8120733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Foreign particle contamination in high volume injectable solutions and in powders for injectable solutions. Proposals for an Italian standard].
    Montanari L; Pavanetto F; Ponci R
    Farmaco Prat; 1983 Dec; 37(12):397-407. PubMed ID: 6822286
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: More on the particulate contamination of carbenicillin injectable products.
    Jeffrey LP; Pinkus TF
    Am J Hosp Pharm; 1974 Apr; 31(4):334-5. PubMed ID: 4822020
    [No Abstract]   [Full Text] [Related]  

  • 15. [The foreign particles in injectable solutions].
    Cavatorta L; Pietra E; Allievi R
    Boll Chim Farm; 1969 Aug; 108(8):488-98. PubMed ID: 5354286
    [No Abstract]   [Full Text] [Related]  

  • 16. Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program.
    Summers A
    Int J Pharm Compd; 2022; 26(4):309-315. PubMed ID: 35820137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contamination control in contract filling of small volume parenterals.
    Sherman NE
    Bull Parenter Drug Assoc; 1970; 24(3):148-52. PubMed ID: 5422903
    [No Abstract]   [Full Text] [Related]  

  • 18. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy--United States, July-November 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Dec; 51(49):1109-12. PubMed ID: 12530707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pyrogenicity and microbiota of injectable solutions].
    Lena P
    Boll Chim Farm; 1980 Jan; 119(1):1-22. PubMed ID: 7447998
    [No Abstract]   [Full Text] [Related]  

  • 20. Particulate matter in cephalosporin injections.
    Mioduch HJ; Czaplicki AD; Schulz BG
    Am J Hosp Pharm; 1983 Nov; 40(11):1982-3. PubMed ID: 6650530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.